Study #2022-0297
Comprehensive Monitoring of Men with Prostate Cancer Cared for by "Active Surveillance"
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Prostate cancer is the most commonly diagnosed cancer in men. However, there is a wide range in prognosis determined by a host of factors. This study will evaluate the feasibility of guiding therapeutic intervention electronically facilitated symptom and disease monitoring in patients being followed on Active Surveillance. Additionally, we will develop a tissue and data resource to support discovery and hypothesis generation to evaluate germline and/or somatic alterations in relation to cancer-specific and overall outcomes..
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Prostate Cancer
Study phase:
Physician name:
Christopher Logothetis
Department:
Genitourinary Medical Oncology
For general questions about clinical trials:
1-833-767-1887
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.